Hemab Therapeutics Holdings COAG Revenue Breakdown

NASDAQ COAG
$48.51 +2.94 (+6.45%)
As of: Nov 6, 2026 · 11:58 AM EST
No revenue breakdown for COAG Hemab Therapeutics Holdings does not report revenue split by segment, product or geography.